PANE, FABRIZIO
PANE, FABRIZIO
DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA
DIRECT-DETECTION OF PROVIRAL GAG SEGMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS IN PERIPHERAL-BLOOD LYMPHOCYTES BY COLORIMETRIC PCR ASSAY AS A CLINICAL LABORATORY TOOL APPLIED TO DIFFERENT AT-RISK POPULATIONS
1995 Pane, Fabrizio; Butto, S.; Gobbo, M. L.; Franco, M.; Butteroni, C.; Pastore, Lucio; Maiorano, G.; Foggia, M.; Cataldo, P. T.; Guarino, A.; Tamburrini, E.; Solinas, S.; Piazza, M.; Vecchio, Giancarlo; Verani, P.; Salvatore, Francesco
In vitro acquired cellular senescence and aging specific phenotype can be distinguished on the basis of specific mRNA expression.
2002 Faraonio, Raffaella; Pane, Fabrizio; Intrieri, M.; Russo, Tommaso; Cimino, F.
In vitro acquired cellular senescence and aging-specific phenotype can be distinguished on the basis of specific mRNA expression
2002 Faraonio, Raffaella; Pane, Fabrizio; Intrieri, M; Russo, T; AND CIMINO, F.
Late relapse of acute promyelocytic leukemia treated with all- trans retinoic acid and chemotherapy: report of two cases.
2004 F., Ferrara; Selleri, Carmine; G., Mele; Serio, Bianca; S., Palmieri; B., Pocali; Pane, Fabrizio; Rotoli, Bruno
JURL-MK1 (c-kit(high)/CD30-/CD40-) and JURL-MK2 (c-kit(low)/CD30+/CD40+) cell lines: 'two-sided' model for investigating leukemic megakaryocytopoiesis.
1997 DI NOTO, Rosa; Luciano, Luigia; Lo Pardo, C.; Ferrara, F.; Frigeri, F.; Mercuro, O.; Lombardi, M. L.; Pane, Fabrizio; Vacca, C.; Manzo, C.; Salvatore, Francesco; Rotoli, Bruno; DEL VECCHIO, Luigi
Trisomy 13 in a case of myelofibrosis with myeloid metaplasia with early blastic transformation.
1995 Ferrara, F.; Vicari, L.; Festa, B.; DI NOTO, Rosa; Pane, Fabrizio; Sebastio, L.; Cimino, R.
Alterazioni piastriniche: definizione immunologica e molecolare
1998 G., Fratellanza; Pane, Fabrizio; Covelli, Bianca; T., Quarantelli; S., Formisano
PEGYLATED-FILGRASTIM AFTER AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION: SINGLE CENTRE EXPERIENCE
2013 Madonna, Emanuela; Grimaldi, Francesco; Avilia, Simona; Giagnuolo, Giovanna; Marotta, Serena; Pane, Fabrizio; Risitano, ANTONIO MARIA; DE ROSA, Gennaro
Simultaneous occurrence of tetrasomy 21 and trisomy 8 in a patient with early blastic metamorphosis of chronic myeloproliferative disorder.
1995 Sebastio, L.; Ferrara, F.; Vicari, L.; DI NOTO, Rosa; DEL VECCHIO, Luigi; Pane, Fabrizio; Fasanaro, A.; Cimino, R.; Salvatore, Francesco; Ventruto, V.
Decitabine up-regulates the expression of the cancer-associate prame antigen in early chronic phase CML cells.
2003 Pane, Fabrizio; Quintarelli, Concetta; Izzo, Barbara; Martinelli, G.; Intrieri, M.; Luciano, L.; Amabile, M.; Rosti, G.; Saglio, G.; Baccarani, M.; Salvatore, F.
New insights into the Bcr-Abl activity-independent mechanisms of resistance to imatinib mesylate in KCL22 cells: the role of Shp1 and Shp2
2010 Colavita, Irene; Esposito, Nicola; Martinelli, Rosanna; Catanzano, Francesca; Pane, Fabrizio; Ruoppolo, Margherita; Salvatore, Francesco
Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: by the GIMEMA Working Party on Chronic Myeloid Leukemia
2007 Soverini, S; Colarossi, S; Gnani, A; Rosti, G; Castagnetti, F; Poerio, A; Iacobucci, I; Amabile, M; Abruzzese, E; Orlandi, E; Radaelli, F; Ciccone, F; Tiribelli, M; DI LORENZO, R; Caracciolo, C; Izzo, Barbara; Pane, Fabrizio; Saglio, G; Baccarani, M; Martinelli, G.
XM02 PLUS CHEMOTHERAPY IS SAFE AND EFFECTIVE IN STEM CELL MOBILIZATION FOR PATIENTS CANDIDATED TO AUTOLOGOUS STEM CELL TRANSPLANTATION
2013 Grimaldi, Francesco; Madonna, Emanuela; Avilia, Simona; Ricci, P.; Andretta, Claudia; Pane, Fabrizio; Risitano, ANTONIO MARIA; DE ROSA, Gennaro
Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials.
2008 Susan, Branford; Linda, Fletcher; Nicholas, C. P.; Martin C., Müller; Andreas, Hochhaus; Dong Wook, Kim; Jerald P., Radich; Giuseppe, Saglio; Pane, Fabrizio; Suzanne Kamel, Reid; Y., Lynn Wang; Richard D., Press; Kevin, Lynch; Zbigniew, Rudzki; John M., Goldman; Timothy, Hughes
Efficacy and safety of rituximab treatment in patients with progressive transformation of germinal centers after Hodgkin lymphoma in complete remission post-induction chemotherapy and radiotherapy.
2011 Picardi, Marco; Zeppa, P; Ciancia, G; Pettinato, G; Grimaldi, F; Fabbricini, R; Mainolfi, C; Pane, Fabrizio
Identification and role of the hemostasis and thrombosis expert in the National Health System
2014 Rodeghiero, F; Morfini, M; Nozzoli, C; Manotti, C; Violi, F; Castaldo, Giuseppe; Pane, Fabrizio; Biasioli, B; Velati, C.
In vitro acquired cellular senescence and aging-specific phenotype can be distinguished on the basis of specific mRNA expression
2002 Faraonio, Raffaella; Pane, Fabrizio; M., Intrieri; Russo, Tommaso; Cimino, Filiberto
The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase.
2010 Palandri, F; Castagnetti, F; Iacobucci, I; Martinelli, G; Amabile, M; Gugliotta, G; Poerio, A; Testoni, N; Breccia, M; Bocchia, M; Crugnola, M; Rege Cambrin, G; Martino, B; Pierri, I; Radaelli, F; Specchia, G; Pane, Fabrizio; Saglio, G; Rosti, G; Baccarani, M.
Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinib.
2011 Gambacorti Passerini, C; Antolini, L; Mahon, Fx; Guilhot, F; Deininger, M; Fava, C; Nagler, A; Della Casa, Cm; Morra, E; Abruzzese, E; D'Emilio, A; Stagno, F; le Coutre, P; Hurtado Monroy, R; Santini, V; Martino, B; Pane, Fabrizio; Piccin, A; Giraldo, P; Assouline, S; Durosinmi, Ma; Leeksma, O; Pogliani, Em; Puttini, M; Jang, E; Reiffers, J; Valsecchi, Mg; Kim, Dw
Key concepts and critical issues on epoetin and filgrastim biosimilars. A position paper from the Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation.
2011 Barosi, G; Bosi, A; Abbracchio, Mp; Danesi, R; Genazzani, A; Corradini, P; Pane, Fabrizio; Tura, S.
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| DIRECT-DETECTION OF PROVIRAL GAG SEGMENT OF HUMAN-IMMUNODEFICIENCY-VIRUS IN PERIPHERAL-BLOOD LYMPHOCYTES BY COLORIMETRIC PCR ASSAY AS A CLINICAL LABORATORY TOOL APPLIED TO DIFFERENT AT-RISK POPULATIONS | 1.1 Articolo in rivista | 1995 | Pane, Fabrizio; Butto, S.; Gobbo, M. L.; Franco, M.; Butteroni, C.; Pastore, Lucio; Maiorano, G.; Foggia, M.; Cataldo, P. T.; Guarino, A.; Tamburrini, E.; Solinas, S.; Piazza, M.; Vecchio, Giancarlo; Verani, P.; Salvatore, Francesco | |
| In vitro acquired cellular senescence and aging specific phenotype can be distinguished on the basis of specific mRNA expression. | 1.1 Articolo in rivista | 2002 | Faraonio, Raffaella; Pane, Fabrizio; Intrieri, M.; Russo, Tommaso; Cimino, F. | |
| In vitro acquired cellular senescence and aging-specific phenotype can be distinguished on the basis of specific mRNA expression | 1.1 Articolo in rivista | 2002 | Faraonio, Raffaella; Pane, Fabrizio; Intrieri, M; Russo, T; AND CIMINO, F. | |
| Late relapse of acute promyelocytic leukemia treated with all- trans retinoic acid and chemotherapy: report of two cases. | 1.1 Articolo in rivista | 2004 | F., Ferrara; Selleri, Carmine; G., Mele; Serio, Bianca; S., Palmieri; B., Pocali; Pane, Fabrizio; Rotoli, Bruno | |
| JURL-MK1 (c-kit(high)/CD30-/CD40-) and JURL-MK2 (c-kit(low)/CD30+/CD40+) cell lines: 'two-sided' model for investigating leukemic megakaryocytopoiesis. | 1.1 Articolo in rivista | 1997 | DI NOTO, Rosa; Luciano, Luigia; Lo Pardo, C.; Ferrara, F.; Frigeri, F.; Mercuro, O.; Lombardi, M. L.; Pane, Fabrizio; Vacca, C.; Manzo, C.; Salvatore, Francesco; Rotoli, Bruno; DEL VECCHIO, Luigi | |
| Trisomy 13 in a case of myelofibrosis with myeloid metaplasia with early blastic transformation. | 1.1 Articolo in rivista | 1995 | Ferrara, F.; Vicari, L.; Festa, B.; DI NOTO, Rosa; Pane, Fabrizio; Sebastio, L.; Cimino, R. | |
| Alterazioni piastriniche: definizione immunologica e molecolare | 1.5 Abstract in rivista | 1998 | G., Fratellanza; Pane, Fabrizio; Covelli, Bianca; T., Quarantelli; S., Formisano | |
| PEGYLATED-FILGRASTIM AFTER AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION: SINGLE CENTRE EXPERIENCE | 4.3 Poster | 2013 | Madonna, Emanuela; Grimaldi, Francesco; Avilia, Simona; Giagnuolo, Giovanna; Marotta, Serena; Pane, Fabrizio; Risitano, ANTONIO MARIA; DE ROSA, Gennaro | |
| Simultaneous occurrence of tetrasomy 21 and trisomy 8 in a patient with early blastic metamorphosis of chronic myeloproliferative disorder. | 1.1 Articolo in rivista | 1995 | Sebastio, L.; Ferrara, F.; Vicari, L.; DI NOTO, Rosa; DEL VECCHIO, Luigi; Pane, Fabrizio; Fasanaro, A.; Cimino, R.; Salvatore, Francesco; Ventruto, V. | |
| Decitabine up-regulates the expression of the cancer-associate prame antigen in early chronic phase CML cells. | 1.5 Abstract in rivista | 2003 | Pane, Fabrizio; Quintarelli, Concetta; Izzo, Barbara; Martinelli, G.; Intrieri, M.; Luciano, L.; Amabile, M.; Rosti, G.; Saglio, G.; Baccarani, M.; Salvatore, F. | |
| New insights into the Bcr-Abl activity-independent mechanisms of resistance to imatinib mesylate in KCL22 cells: the role of Shp1 and Shp2 | 4.1 Articoli in Atti di convegno | 2010 | Colavita, Irene; Esposito, Nicola; Martinelli, Rosanna; Catanzano, Francesca; Pane, Fabrizio; Ruoppolo, Margherita; Salvatore, Francesco | |
| Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: by the GIMEMA Working Party on Chronic Myeloid Leukemia | 1.1 Articolo in rivista | 2007 | Soverini, S; Colarossi, S; Gnani, A; Rosti, G; Castagnetti, F; Poerio, A; Iacobucci, I; Amabile, M; Abruzzese, E; Orlandi, E; Radaelli, F; Ciccone, F; Tiribelli, M; DI LORENZO, R; Caracciolo, C; Izzo, Barbara; Pane, Fabrizio; Saglio, G; Baccarani, M; Martinelli, G. | |
| XM02 PLUS CHEMOTHERAPY IS SAFE AND EFFECTIVE IN STEM CELL MOBILIZATION FOR PATIENTS CANDIDATED TO AUTOLOGOUS STEM CELL TRANSPLANTATION | 4.2 Abstract in Atti di convegno | 2013 | Grimaldi, Francesco; Madonna, Emanuela; Avilia, Simona; Ricci, P.; Andretta, Claudia; Pane, Fabrizio; Risitano, ANTONIO MARIA; DE ROSA, Gennaro | |
| Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials. | 1.1 Articolo in rivista | 2008 | Susan, Branford; Linda, Fletcher; Nicholas, C. P.; Martin C., Müller; Andreas, Hochhaus; Dong Wook, Kim; Jerald P., Radich; Giuseppe, Saglio; Pane, Fabrizio; Suzanne Kamel, Reid; Y., Lynn Wang; Richard D., Press; Kevin, Lynch; Zbigniew, Rudzki; John M., Goldman; Timothy, Hughes | |
| Efficacy and safety of rituximab treatment in patients with progressive transformation of germinal centers after Hodgkin lymphoma in complete remission post-induction chemotherapy and radiotherapy. | 1.1 Articolo in rivista | 2011 | Picardi, Marco; Zeppa, P; Ciancia, G; Pettinato, G; Grimaldi, F; Fabbricini, R; Mainolfi, C; Pane, Fabrizio | |
| Identification and role of the hemostasis and thrombosis expert in the National Health System | 1.1 Articolo in rivista | 2014 | Rodeghiero, F; Morfini, M; Nozzoli, C; Manotti, C; Violi, F; Castaldo, Giuseppe; Pane, Fabrizio; Biasioli, B; Velati, C. | |
| In vitro acquired cellular senescence and aging-specific phenotype can be distinguished on the basis of specific mRNA expression | 1.1 Articolo in rivista | 2002 | Faraonio, Raffaella; Pane, Fabrizio; M., Intrieri; Russo, Tommaso; Cimino, Filiberto | |
| The response to imatinib and interferon-alpha is more rapid than the response to imatinib alone: a retrospective analysis of 495 Philadelphia-positive chronic myeloid leukemia patients in early chronic phase. | 1.1 Articolo in rivista | 2010 | Palandri, F; Castagnetti, F; Iacobucci, I; Martinelli, G; Amabile, M; Gugliotta, G; Poerio, A; Testoni, N; Breccia, M; Bocchia, M; Crugnola, M; Rege Cambrin, G; Martino, B; Pierri, I; Radaelli, F; Specchia, G; Pane, Fabrizio; Saglio, G; Rosti, G; Baccarani, M. | |
| Multicenter independent assessment of outcomes in chronic myeloid leukemia patients treated with imatinib. | 1.1 Articolo in rivista | 2011 | Gambacorti Passerini, C; Antolini, L; Mahon, Fx; Guilhot, F; Deininger, M; Fava, C; Nagler, A; Della Casa, Cm; Morra, E; Abruzzese, E; D'Emilio, A; Stagno, F; le Coutre, P; Hurtado Monroy, R; Santini, V; Martino, B; Pane, Fabrizio; Piccin, A; Giraldo, P; Assouline, S; Durosinmi, Ma; Leeksma, O; Pogliani, Em; Puttini, M; Jang, E; Reiffers, J; Valsecchi, Mg; Kim, Dw | |
| Key concepts and critical issues on epoetin and filgrastim biosimilars. A position paper from the Italian Society of Hematology, Italian Society of Experimental Hematology, and Italian Group for Bone Marrow Transplantation. | 1.1 Articolo in rivista | 2011 | Barosi, G; Bosi, A; Abbracchio, Mp; Danesi, R; Genazzani, A; Corradini, P; Pane, Fabrizio; Tura, S. |